Log In

Press Releases

Take a look at a selection of our recent media coverage:

Hypertrophic Cardiomyopathy (HCM): Diagnosis, Natural History, and Management Considerations

5 October 2021

This e-learning module is designed to provide you with an understanding of how HCM can be diagnosed, managed, and treated. It assists cardiologists and other healthcare practitioners with an interest in HCM management to:

  • improve diagnosis
  • more accurately target treatments for heart failure based on an individual patient’s clinical profile
  • implement strategies for sudden death prevention
  • appreciate when referral to an HCM expert center may be appropriate.

The module should take about 60 minutes to complete, dependent on your level of knowledge. We begin with a pre-assessment of your understanding of HCM. Then, there are seven topics and a post-assessment. As soon as you complete a topic, the next topic will be unlocked.

Hypertrophic cardiomyopathy patient case study: Advanced

8 July 2021

This module is an advanced-level, interactive case study, of a 45-year-old female, looking into the possible differential diagnoses with her signs/symptoms. The case study covers obstructive vs nonobstructive hypertrophic cardiomyopathy (HCM) alongside other cardiovascular and pulmonary conditions. Throughout the case study and the investigative procedures described, we cover the different types of HCM and the symptoms associated with each.

The case study aims to support a differential diagnosis of obstructive or non-obstructive HCM from other cardiovascular or pulmonary conditions and support best practice in referral to expert centres.

HCM patient case study: Foundation

This module is a foundation level case study which gives an overview of the presentation and symptoms of hypertrophic cardiomyopathy (HCM). It is a case study of a 19-yr old male with suspected HCM that walks through the diagnostic approaches, risk assessment, and key considerations associated with the condition.

The case study aims to educate on earlier identification of patients with suspected HCM and support timely diagnosis/management.